Cerebral embolic protection devices during transcatheter aortic valve implantation: clinical versus silent embolism

J Thorac Dis. 2018 Nov;10(Suppl 30):S3604-S3613. doi: 10.21037/jtd.2018.09.62.

Abstract

Cerebrovascular events following transcatheter aortic valve implantation (TAVI) is one of the most devastating complications. Several studies with magnetic resonance or cerebral filters have demonstrated the universal brain embolization after TAVI, in the majority of patients clinically silent. Embolic protection devices (EPD) have been developed as a mechanical barrier to prevent these emboli to reach cerebral vasculature and potentially reduce neurological events. We review the current evidence about EPD in relation to histopathological and cerebral imaging findings and neurological events.

Keywords: Transcatheter aortic valve implantation (TAVI); embolic protection device (EPD); stroke, cerebrovascular events; transcatheter aortic valve replacement (TAVR).

Publication types

  • Review